United States - English - NLM (National Library of Medicine)

bryant ranch prepack - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine hydrochloride nasal solution (nasal spray) is indicated for the relief of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 years of age and older. none. risk summary published data from postmarketing experience with antihistamines, with similar mechanism of action to olopatadine hydrochloride nasal solution (nasal spray), have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. however, there are no published human data specific to olopatadine hydrochloride nasal solution (nasal spray). in animal reproductive studies, oral administration of olopatadine hydrochloride to pregnant rats and rabbits caused a decrease in the number of live fetuses at maternal doses approximately 110 and 1460 times the maximum recommended human daily intranasal dose (mrhdid) on a mg/m2 basis, respectively (see data) . the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all

United States - English - NLM (National Library of Medicine)

a-s medication solutions - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine hydrochloride ophthalmic solution usp, 0.1% is indicated for the treatment of the signs and symptoms of allergic conjunctivitis. olopatadine hydrochloride ophthalmic solution, 0.1% is contraindicated in persons with a known hypersensitivity to olopatadine hydrochloride or any components of olopatadine hydrochloride ophthalmic solution, 0.1%. olopatadine hydrochloride ophthalmic solution, 0.1% is for topical use only and not for injection or oral use.

United States - English - NLM (National Library of Medicine)

rpk pharmaceuticals, inc. - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - olopatadine hydrochloride ophthalmic solution usp, 0.1% is indicated for the treatment of the signs and symptoms of allergic conjunctivitis. olopatadine hydrochloride ophthalmic solution, 0.1% is contraindicated in persons with a known hypersensitivity to olopatadine hydrochloride or any components of olopatadine hydrochloride ophthalmic solution, 0.1%. olopatadine hydrochloride ophthalmic solution, 0.1% is for topical use only and not for injection or oral use.

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - antihistamine and redness reliever temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander.

United States - English - NLM (National Library of Medicine)

akorn - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - antihistamine temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander.

United States - English - NLM (National Library of Medicine)

akorn - olopatadine hydrochloride (unii: 2xg66w44kf) (olopatadine - unii:d27v6190pm) - antihistamine and redness reliever temporarily relieves itchy and red eyes due to pollen, ragweed, grass, animal hair and dander.

Canada - English - Health Canada

teva canada limited - olopatadine (olopatadine hydrochloride) - solution - 0.2% - olopatadine (olopatadine hydrochloride) 0.2% - antiallergic agents

Canada - English - Health Canada

sandoz canada incorporated - olopatadine (olopatadine hydrochloride) - solution - 0.2% - olopatadine (olopatadine hydrochloride) 0.2% - antiallergic agents

Canada - English - Health Canada

sandoz canada incorporated - olopatadine (olopatadine hydrochloride) - solution - 0.1% - olopatadine (olopatadine hydrochloride) 0.1% - antiallergic agents

Canada - English - Health Canada

teva canada limited - olopatadine (olopatadine hydrochloride) - solution - 0.1% - olopatadine (olopatadine hydrochloride) 0.1% - antiallergic agents